PP
RGNX icon

PDT Partners’s Regenxbio RGNX Stock Holding History

PDT Partners’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-102,516
Closed -$733K – 818
2025
Q1 		$733K Buy
102,516
+39,501
+63% +$294K 0.05% 451
2024
Q4 		$487K Buy
+63,015
New +$592K 0.04% 489
2024
Q3 		– Sell
-34,412
Closed -$403K – 804
2024
Q2 		$403K Buy
34,412
+25
+0.1% +$389 0.04% 512
2024
Q1 		$725K Buy
+34,387
New +$612K 0.07% 387
2022
Q4 		– Sell
-8,906
Closed -$235K – 852
2022
Q3 		$235K Sell
8,906
-6,479
-42% -$192K 0.04% 667
2022
Q2 		$380K Buy
15,385
+1,360
+10% +$34K 0.03% 682
2022
Q1 		$465K Buy
14,025
+3,025
+28% +$84K 0.04% 609
2021
Q4 		$360K Buy
+11,000
New +$375K 0.03% 625
2021
Q3 		– Sell
-50,331
Closed -$1.96M – 888
2021
Q2 		$1.96M Sell
50,331
-13,646
-21% -$488K 0.13% 272
2021
Q1 		$2.18M Buy
63,977
+18,987
+42% +$810K 0.16% 255
2020
Q4 		$2.04M Sell
44,990
-18,333
-29% -$641K 0.14% 247
2020
Q3 		$1.74M Buy
63,323
+41,657
+192% +$1.36M 0.12% 228
2020
Q2 		$798K Buy
+21,666
New +$808K 0.05% 318
2018
Q3 		– Sell
-42,946
Closed -$3.08M – 530
2018
Q2 		$3.08M Buy
42,946
+13,100
+44% +$626K 0.12% 203
2018
Q1 		$891K Buy
+29,846
New +$869K 0.03% 364

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

PDT Partners's RGNX Position: Q2 2025 in Review

PDT Partners sold out of Regenxbio (RGNX) in Q2 2025, closing a stake of 102,516 shares — an estimated $733K sold.

PDT Partners first reported a position in RGNX in Q1 2018 and held it in 15 quarters. The position peaked at $3.08M in Q2 2018. 159 funds tracked by Wall St. Rank hold RGNX as of Q2 2025.

  • PDT Partners reported no remaining Regenxbio position as of Q2 2025 after selling out during the quarter.
  • PDT Partners sold 102,516 Regenxbio shares in Q2 2025, an estimated $733K.
  • PDT Partners first reported a position in Regenxbio in Q1 2018 and held it in 15 quarters.
  • PDT Partners's Regenxbio position peaked at $3.08M in Q2 2018.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q2 2025.

Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.